Pharmaceutical Industry
Page 10 of 100
By Luisa BeltranOctober 31, 2024
RetailBritish pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
By AFPOctober 30, 2024
By Madison Muller and BloombergOctober 29, 2024
By Alexa MikhailOctober 29, 2024
By Ashleigh Furlong, Tim Loh and BloombergOctober 25, 2024
CommentaryAs activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By Jeffrey Sonnenfeld and Steven TianOctober 24, 2024
HealthPneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination
By Lindsey LeakeOctober 22, 2024
LeadershipHow Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
By John KellOctober 22, 2024
HealthFrench government ‘must block the sale’ of Sanofi’s Doliprane painkiller to U.S. private equity, critics argue
By Jurgen Hecker, Tom Barfield and AFPOctober 22, 2024
Leadership23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By Lila MacLellanOctober 17, 2024
CommentaryThe world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns
By Jano CostardOctober 16, 2024
RetailFrance’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
By Jurgen Hecker and AFPOctober 15, 2024
Most Popular
